The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

To celebrate Muni Art Week, we'll take a stroll back in time for a quick look at a sampling of the various Muni logos that have adorned Muni's vehicles and signs throughout the years. Taking snippets ...

Explore the evolution and history of the Google logo design, from its humble beginnings as a simple wordmark to its iconic multi-coloured iteration. Google is one of the most widely used companies in ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

Banco Santander topped Stoxx 600 gains, up 8.3%, after the Spanish lender reported record quarterly profit. Pharma giant GSK closed 7.6% higher after hiking its long-term sales guidance and posting ...

British pharmaceutical giant GSK raised its long-term sales guidance on Wednesday as it posted a rise in full-year core operating profit and forecast sales growth of up to 5% in 2025. GSK's core ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares opened today ...

GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

GlaxoSmithKline, one of the world’s largest healthcare and pharmaceutical companies, has announced it will pay US$ 3 billion in order to settle a U.S. scandal over drug fraud. Under the terms of ...